MycoTOX Articles and Webinars
Webinar
Articles
Evan Brand, FTNP
Evan Brand, FTNP, shares his experiences, assessments, and protocols helping patients recover from mycotoxin exposure. Learn best practices for diagnosing and creating a care plan to treat patients who are experiencing pain, fog, behavioral issues due to mycotoxin exposure.
Kurt Woeller, DO
Various molds like Aspergillus can produce toxic chemical compounds that damage cellular function. The mold itself can trigger immune reactions which drive inflammation, but mycotoxins (aka mold toxins) have their own chemical properties when targeted against the kidneys and liver which can lead to detoxification interference. This lecture by Kurt N. Woeller, D.O. will discuss some of the mechanisms involved that underlie liver and kidney problems linked to certain mold toxins.
Kurt Woeller, DO
Mycotoxins are toxic compounds produced by many different types of molds. A certain group of mycotoxins called trichothecenes are a large group of chemically related compounds produced by such molds as Fusarium and Stachybotrys. Trichothecenes have some unique toxicity effects, including on cellular production of proteins, DNA synthesis, and more. This lecture will explore various mycotoxins within the trichothecene family and some of their related cytotoxicities.
Speaker: James Neuenschwander, MD
Are you or someone you know suffering from petroleum poisoning in Oahu?
Kurt Woeller, DO
Vitamin D is an essential nutrient well known for its role in immune function, bone metabolism, and reduction in cardiovascular diseases. However, there are other less-known effects of vitamin D that this lecture will explore, including its influence on cellular metabolism linked to mitochondrial activity and neurochemical regulation within the nervous system.
Kurt Woeller, DO
Various mycotoxins can have significant adverse effects with regards to cellular function. Through DNA and RNA disruption and/or induction of oxidative stress mycotoxins can lead to various diseases, including cancer. A major target of intracellular mycotoxins are the mitochondria. This lecture by Dr. Kurt Woeller will discuss some of the cytotoxic effects of mycotoxins on mitochondrial function.
Kurt Woeller, DO
The Organic Acids Test (OAT) contains multiple markers which may be influenced by environmental and mold toxins. Often the combination of the OAT, MycoTOX Profile (mold toxins), and GPL-TOX Profile (environmental chemical toxins) can be used to help identify exposure sources and biochemical imbalances in individuals with chronic health conditions. This presentation by Kurt N. Woeller, DO will help connect some of the more common findings seen in practice when evaluating these three tests.
Kurt Woeller, DO, Dane Johnson, CHN, and Jon Sheflet discuss how the OAT and MycoTOX Profile play a role in the recovery of patients with Crohns/Colitis.
Kurt Woeller, DO
Various candida organisms can be normal inhabitants of the digestive system and part of the microbiome in low levels. However, candida has the potential to overpopulate the bowel leading to various symptoms of bloating, gas, constipation, etc. Candida can also become invasive within the digestive system leading to leaky gut and increasing mucosal immune activity and systemic reactivity. This will be a special roundtable discussion allowing practitioners to submit specific case studies and will focus more on direct Q&A on specific case studies.
In this live webinar, hosted by Autism Research Coalition, William Shaw, PhD & Sidney Baker, MD discussed their latest publication "Case Study: Rapid Complete Recovery From An Autism Spectrum Disorder After Treatment of Aspergillus With The Antifungal Drugs Itraconazole And Sporanox" (2020).
As noted in the publication, "Escalation of the dose of itraconazole resulted in a complete loss of all symptoms of Autism over the course of 3 months. This rapid complete reversal of Autism is consistent with several articles proposing mold in general and Aspergillus specifically as a potential major cause of Autism."
Dr. Sidney Baker was the co-founder of Defeat Autism Now!, a national organization devoted to dialog among parents, practitioners and scientists regarding biomedical treatment options and the environmental origins of the current Autism epidemic. He received his undergraduate, medical, and medical postgraduate training from Yale University where he served as Chief Resident in Pediatrics on the full-time medical faculty. He is the author of multiple books and publications and was the 1999 recipient of the Linus Pauling Award of the Institute for Functional Medicine for his contributions to the development of Functional Medicine, to name a few achievements.
Dr. William Shaw is board certified in the fields of clinical chemistry and toxicology by the American Board of Clinical Chemistry and the founder of The Great Plains Laboratory. Dr. Shaw worked for the Centers for Disease Control and Prevention (CDC), Children's Mercy Hospital, University of Missouri at Kansas City School of Medicine, and Smith Kline Laboratories. He is the author of Biological Treatments for Autism and PDD, originally published in 1998 and Autism: Beyond the Basics, published in 2009. Dr. Shaw is the stepfather of a child with Autism and has helped thousands of patients and medical practitioners to successfully improve the lives of people with autism, ADHD, Alzheimer's disease, and other serious conditions.
In a live webinar, presented by the Autism Research Coalition, William Shaw, PhD reviewed his research that identified several compounds in the urine of children with Autism Spectrum Disorder (ASD) using gas chromatography mass spectrometry. Many of these compounds (elevated in ASD) were associated with the presence of mold and yeast in the gastrointestinal tract. The children with ASD had significantly higher values compared to healthy controls in these compounds.
Antifungal therapy as a treatment for ASD became much more common throughout the world because of this study and the concerted efforts by Dr. Sidney Baker to use what he called the “antifungal parade” to treat ASD, although it was not completely clear if the benefits of antifungal treatments were due to the control of yeast (Candida), mold, or both. Recently Dr. Baker treated a young boy with significant ASD using the drugs Itraconazole and Sporanox, drugs that are very useful for the control of many molds. As a result of the treatment, the child had a complete and very rapid recovery from ASD. Testing at The Great Plains Laboratory found that the child’s rapid recovery correlated with a drastic drop in metabolites associated with the mold Aspergillus.